Reports for APOTEX INC
Company Name APOTEX INC |
||
---|---|---|
Totals |
||
Shortage reports |
3367 |
|
Actual shortage: | 219 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 341 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-LISINOPRIL TABLET 10 MG | 10MG | TABLET | Resolved | 2022-02-04 | 2022-03-24 | 154178 |
APO-LISINOPRIL TABLET 10 MG | 10MG | TABLET | Resolved | 2017-05-04 | 2017-06-23 | 8868 |
APO-LISINOPRIL TABLET 20 MG | 20MG | TABLET | Resolved | 2020-07-29 | 2020-10-05 | 121328 |
APO-LISINOPRIL TABLET 20 MG | 20MG | TABLET | Resolved | 2020-11-19 | 2021-03-15 | 128606 |
APO-LISINOPRIL TABLET 20 MG | 20MG | TABLET | Resolved | 2017-10-17 | 2018-01-26 | 26166 |
APO-LISINOPRIL TABLET 5 MG | 5MG | TABLET | Resolved | 2017-09-06 | 2017-12-31 | 21085 |
APO-LISINOPRIL TABLET 5 MG | 5MG | TABLET | Resolved | 2020-08-19 | 2020-10-05 | 122483 |
APO-LISINOPRIL TABLET 5 MG | 5MG | TABLET | Resolved | 2020-10-14 | 2021-03-15 | 126292 |
APO-LITHIUM CARBONATE | 150MG | CAPSULE | Resolved | 2017-11-28 | 2018-01-10 | 30935 |
APO-LITHIUM CARBONATE | 300MG | CAPSULE | Resolved | 2017-11-28 | 2018-01-10 | 30938 |
APO-LITHIUM CARBONATE | 150MG | CAPSULE | Resolved | 2018-01-22 | 2018-02-13 | 36821 |
APO-LITHIUM CARBONATE | 150MG | CAPSULE | Resolved | 2024-04-19 | 2024-05-22 | 225802 |
APO-LITHIUM CARBONATE | 300MG | CAPSULE | Resolved | 2018-05-15 | 2018-09-11 | 49367 |
APO-LITHIUM CARBONATE | 300MG | CAPSULE | Actual shortage | 2025-01-10 | 2025-02-06 | 247458 |
APO-LITHIUM CARBONATE | 300MG | CAPSULE | Resolved | 2017-07-26 | 2017-10-31 | 17254 |
APO-LITHIUM CARBONATE | 300MG | CAPSULE | Resolved | 2024-05-03 | 2024-12-20 | 227079 |
APO-LOPERAMIDE - TAB 2MG | 2MG | TABLET | Actual shortage | 2017-03-10 | 2017-10-05 | 372 |
APO-LORATADINE | 10MG | TABLET | Resolved | 2025-01-09 | 2025-04-17 | 247397 |
APO-LORAZEPAM | 0.5MG | TABLET | Resolved | 2024-06-27 | 2024-09-20 | 231484 |
APO-LORAZEPAM | 1MG | TABLET | Resolved | 2024-07-12 | 2024-09-20 | 232846 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |